Changchun GeneScience Pharmaceuticals Co., Ltd.

  • 1111.jpg sj.jpg
    Pioneering Breakthrough Therapies
    for Global Patients

RESEARCH AND DEVELOPMENT

Sustaining Innovation...

  • 30+

    Marketed Products

  • 40+

    Pipeline

  • 26.5%

    R&D investment
    (% of 2025 revenue)

To challenge, create, and push the boundaries of possibility.